You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API penicillamine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing penicillamine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Bausch Health US LLC CUPRIMINE penicillamine 25010-705 D&C YELLOW NO. 10
Bausch Health US LLC CUPRIMINE penicillamine 25010-705 GELATIN
Bausch Health US LLC CUPRIMINE penicillamine 25010-705 LACTOSE MONOHYDRATE
Bausch Health US LLC CUPRIMINE penicillamine 25010-705 MAGNESIUM STEARATE
Bausch Health US LLC CUPRIMINE penicillamine 25010-705 TITANIUM DIOXIDE
Oceanside Pharmaceuticals PENICILLAMINE penicillamine 68682-020 D&C YELLOW NO. 10
Oceanside Pharmaceuticals PENICILLAMINE penicillamine 68682-020 GELATIN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing penicillamine

Company Ingredient NDC Excipient
Par Pharmaceutical Inc penicillamine 0254-2000 ANHYDROUS LACTOSE
Par Pharmaceutical Inc penicillamine 0254-2000 COPOVIDONE K25-31
Par Pharmaceutical Inc penicillamine 0254-2000 EDETATE DISODIUM
Par Pharmaceutical Inc penicillamine 0254-2000 HYPROMELLOSE 2910
Par Pharmaceutical Inc penicillamine 0254-2000 LACTOSE MONOHYDRATE
Par Pharmaceutical Inc penicillamine 0254-2000 MAGNESIUM STEARATE
Par Pharmaceutical Inc penicillamine 0254-2000 MAGNESIUM TRISILICATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for penicillamine

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

penicillamine drug variants not containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Par Pharmaceutical Inc penicillamine 0254-2000
Actavis Pharma Inc penicillamine 0591-4171
Bausch Health US LLC penicillamine 25010-705
ANI Pharmaceuticals Inc penicillamine 43975-309
Par Pharmaceutical Inc penicillamine 49884-146
Breckenridge Pharmaceutical Inc penicillamine 51991-974
ANI Pharmaceuticals Inc penicillamine 62559-970
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: COPOVIDONE K25-31

Excipient focus: D&C YELLOW NO. 10

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE SODIUM

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MAGNESIUM TRISILICATE

Excipient focus: MANNITOL

Excipient focus: POLYETHYLENE GLYCOL 3350

penicillamine drug variants not containing POLYETHYLENE GLYCOL 3350

Company Ingredient NDC
Par Pharmaceutical Inc penicillamine 0254-2000
Actavis Pharma Inc penicillamine 0591-4171
Bausch Health US LLC penicillamine 25010-705
Dr Reddy's Laboratories Inc penicillamine 43598-634
ANI Pharmaceuticals Inc penicillamine 43975-309
Par Pharmaceutical Inc penicillamine 49884-146
Breckenridge Pharmaceutical Inc penicillamine 51991-974
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group